Editorial

Switching Anti–Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration

Dr Schachat is the Vice Chairman of the Cole Eye Institute at the Cleveland Clinic in Cleveland, Ohio and Professor of Ophthalmology at the Lerner College of Medicine.

Dr Schachat was editor-in-chief of Ophthalmology for ten years from 2003-2012. He has served as the secretary for Quality of Care from 1996 to 2001 for the American Academy of Ophthalmology and has served on many Academy committees, including the EyeNet Editorial Advisory Board, Bylaws and Rules committee, Outcomes Program committee, and Basic and Clinical Science Course committee.

Dr Schachat received his medical degree in 1979 at Johns Hopkins University and completed his ophthalmology residency training at the Wilmer Institute at Johns Hopkins (1982), and his retina and oncology fellowship at the Wills Eye hospital in Philadelphia (1984).

In 1984 he was the Assistant Chief of Service at Wilmer, and remained at Wilmer until 2006 when he joined the Cleveland Clinic. He was president of the Maryland Society of Eye Physicians and Surgeons in 2001. He is a former associate editor of the Archives of Ophthalmology and a current editor of two volumes of Ryan's Retina, fifth edition (2012).

Dr Schachat was the interim chair at the Cole Eye Institute, Cleveland Clinic in 2008 and remains vice chairman for Clinical Affairs at the Cole Eye Institute, Cleveland Clinic and director of Clinical Research. He is the former Karl Hagen Professor of Ophthalmology and Vice Chairman of Safety and Quality of the Department of Ophthalmology, and Director of the Ocular Oncology Service at the Johns Hopkins University. He was also professor of Oncology at Johns Hopkins.